Atlas Trials

Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas

Clinical trial NCT03277924 · COMPLETED

Trial details

NCT number
NCT03277924
Sponsor
Grupo Espanol de Investigacion en Sarcomas
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Soft Tissue SarcomaBone Sarcoma
Start date
2017-05-31
Primary completion
2024-06-30
Enrollment
197

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.